UPDATE : Saturday, March 24, 2018
Hanmi to recruit 200 employees in bio, R&D sector
Hanmi Pharmaceuticals said Friday it plans to recruit 200 people in the sec...
by Constance Williams  |  2017-08-11 16:05
‘Moon Jae-in care’ keeps industry busy weighing bottom lines
After President Moon Jae-in announced a policy to drastically expand health...
by Park Gi-taek  |  2017-08-11 13:42
Daewoong launches venous insufficiency drug
Daewoong Pharmaceuticals대웅제약 (CEO Lee Jong-wook이종욱) has launched Centelight...
by Constance Williams  |  2017-08-11 10:59
LG Chem releases sharply improved reagent
LG ChemLG화학 has launched a reagent that can check 93 allergy-causing substa...
by Constance Williams  |  2017-08-10 17:29
Chong Kun Dang announces ‘employee-happy’ management plan
Chong Kun Dang has introduced an “employee-happiness” management system to ...
by Marian Chu  |  2017-08-10 17:29
Korea United gets patent for combined oral formulation tech
Korea United Pharmaceuticals has recently registered a patent for its combi...
by Constance Williams  |  2017-08-10 11:04
Regulators to add cautions against Loxoprofen
The Ministry of Food and Drug Safety (MFDS) will add the warnings of shock ...
by Lee Hye-seon  |  2017-08-09 18:53
Jeil Pharmaceuticals launches ‘global smart factory’
Jeil Pharmaceuticals has begun the operation of its “state-of-the-art globa...
by Constance Williams  |  2017-08-09 12:39
Novartis’ anti-arthritis drug to get insurance benefits
Novartis Korea announced Tuesday that its anti-arthritis drug Cosentyx (ing...
by Constance Williams  |  2017-08-08 16:34
Dong-A Socio chairman arrested for embezzlement, tax avoidance
Dong-A Socio Holdings Chairman Kang Jung-seok was arrested Monday for embez...
by Marian Chu  |  2017-08-08 16:11
Takeda to develop cancer therapy inhibitor
Takeda Pharmaceuticals has made an exclusive licensing agreement with Tesar...
by Constance Williams  |  2017-08-08 15:56
Korea approves phase 3 trials of Lilly’s Alzheimer’s therapy
The Ministry of Food and Drug Safety has approved the extended phase 3 clin...
by Lee Hye-seon  |  2017-08-08 15:10
Korean firms challenge Champix’s dominance in antismoking aid market
Domestic pharmaceutical companies are continuing to challenge Pfizer’s smok...
by Lee Hye-seon  |  2017-08-07 17:47
Regulators to add condition for approving chronic hepatitis B therapy
The Ministry of Food and Drug Safety will add the result of analyzing child...
by Lee Hye-seon  |  2017-08-07 17:42
Daehwa Pharm to use Medidata’s data management solutions
Daehwa Pharmaceuticals will use Medidata’s data management solutions to con...
by Marian Chu  |  2017-08-07 16:39
New osteoporosis therapy causes curiosity about drug price
Ten years have passed since Amgen’s “Prolia,” the so-called first biologica...
by Park Gi-taek  |  2017-08-07 14:42
Handok expands gene testing analysis to children
Handok has expanded its genome testing service to children, the company sai...
by Marian Chu  |  2017-08-07 11:06
Clearer standards for relief of harms from drugs’ side effects
The standards for medical products excluded from the application for the re...
by Lee Hye-seon  |  2017-08-04 18:30
Cosmetics firm acquires external preparations maker
Cosmetics company Tonymoly has bought a 47.6-percent stake of Tai Guk Pharm...
by Lee Hye-seon  |  2017-08-03 16:18
Yungjin’s new drug completes phase 2a clinical trial in US
Yungjin Pharmaceutical has secured the safety of “YPL-001,” a new drug to t...
by Lee Hye-seon  |  2017-08-03 15:42
Back to Top